Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West-Reference-Cited by-同舟云学术

Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West

Published:2020-05-08 Issue:6 Volume:71 Page:1910-1922
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Dang Hansen¹²,Yeo Yee Hui¹,Yasuda Satoshi³,Huang Chung‐Feng⁴^ORCID,Iio Etsuko⁵,Landis Charles⁶,Jun Dae Won⁷^ORCID,Enomoto Masaru⁸,Ogawa Eiichi⁹^ORCID,Tsai Pei‐Chien⁴,Le An¹,Liu Matthew⁶,Maeda Mayumi¹,Nguyen Brian¹,Ramrakhiani Nathan¹,Henry Linda¹,Cheung Ramsey¹¹⁰,Tamori Akihiro⁸,Kumada Takashi³,Tanaka Yasuhito⁵,Yu Ming‐Lung⁴^ORCID,Toyoda Hidenori³,Nguyen Mindie H.¹

Affiliation:

1. Division of Gastroenterology and Hepatology Department of Medicine Stanford University Medical Center Palo Alto CA

2. University of California Davis, Davis CA

3. Department of Gastroenterology Ogaki Municipal Hospital Ogaki Japan

4. Hepatobiliary Division Department of Internal Medicine Kaohsiung Medical University Hospital Kaohsiung Medical University Kaohsiung Taiwan

5. Department of Virology and Liver Unit Nagoya City University Graduate School of Medical Sciences Nagoya Japan

6. Department of Gastroenterology University of Washington Medical Center Seattle WA

7. Department of Gastroenterology Hanyang University Seoul South Korea

8. Department of Hepatology Osaka City University Graduate School of Medicine Osaka Japan

9. Department of General Internal Medicine Kyushu University Hospital Fukuoka Japan

10. Division of Gastroenterology and Hepatology Veterans Affairs Palo Alto Health Care System Palo Alto CA

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30988

Reference34 articles.

1. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002

2. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

3. Hepatocellular Carcinoma – Epidemiological Trends and Risk Factors

4. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

5. Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma;Journal of Clinical Oncology;2024-01-04

2. Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response;Alimentary Pharmacology & Therapeutics;2024-01-03

3. Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis;Hepatology International;2024-01-02

4. Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment;Journal of the Formosan Medical Association;2024-01

5. Regional Differences in Clinical Presentation and Prognosis of Patients With Post–Sustained Virologic Response Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-01